Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-003492

Chief Financial Officer sold 75,000 shares at an average $62.59 ($4,694,543)

  • Chief Financial Officer acquired 75,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cohen Chad M · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-12 Exercise or conversion : show line 1 in the form +75,000 $6.32 $474,000 76,000 D
2021-01-12 Sale : show line 2 in the form −39,973 $62.25 $2,488,319 36,027 D
2021-01-12 Sale : show line 3 in the form −33,827 $62.96 $2,129,748 2,200 D
2021-01-12 Sale : show line 4 in the form −1,200 $63.73 $76,476 1,000 D
Open-market sales · 75,000 sh · avg $62.59 · $4,694,543

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-12 Exercise or conversion : show line 5 in the form Stock Option (Right To Buy) −75,000 415,000 D
Loading xslF345X03/doc4.xml…